Patient-derived organoid facilitating personalized medicine in non-small cell lung cancer: two case reports
{{output}}
Patients with brain metastases from lung cancer exhibit rapid disease progression and a poor prognosis, underscoring an urgent need for effective therapeutic strategies. Drug sensitivity testing using patient-derived organoids (PDOs) has emerged as a promising... ...
